Benefits of clinical pathway implementation in HCC management are examined. In this segment of the panel discussion, the focus was on the importance of data in clinical pathways for treating ...

Please provide your email address to receive an email when new articles are posted on . Researchers validated a liver cancer risk test algorithm for identifying patients with chronic hepatitis C at ...

A risk stratification algorithm may be able to predict which patients with advanced chronic liver disease are at risk of developing hepatocellular carcinoma (HCC), according to a large-scale ...

Hepatocellular carcinoma (HCC) is the most common primary liver tumor, with nearly 85% of cases linked to hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. Other major risk factors ...

Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and one of the leading causes of cancer-related deaths worldwide. Early detection and accurate diagnosis are crucial for effective ...

Hepatocellular carcinoma (HCC) poses a substantial health burden globally, with liver cancer being the fourth most common cause of cancer-related mortality worldwide. In China, where the incidence of ...